- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 1, 2025 | 82.34M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 87.71M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 94.68M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 111.16M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 117.32M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2025 | $400.19M |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $400M |
| Capex | Q3 2025 · Mar 31, 2025 | $60.9M |
| Capex | Q3 2025 · Mar 31, 2024 | $67.63M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | $293.44M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $190.27M |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $0 |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $71.33M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $125.15M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $880.71M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $746.56M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $1.55B |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $1.44B |
| Current Assets | Q3 2025 · Mar 31, 2025 | $576.43M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $755.26M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $3.07B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $3.4B |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | $0.31 |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | $0.02 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.36 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.50 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | $0.31 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | $0.02 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.36 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.50 |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $149.26M |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $537.91M |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $281.16M |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $551.96M |
| Rd Expense | Q3 2025 · Mar 31, 2025 | $633K |
| Rd Expense | Q3 2025 · Mar 31, 2025 | $1.95M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $661K |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $2.45M |
| Operating Income | Q3 2025 · Mar 31, 2025 | $33.76M |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$23.75M |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | −$77.57M |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | $43.67M |
| Gross Profit | Q3 2025 · Mar 31, 2025 | $193.17M |
| Gross Profit | Q3 2025 · Mar 31, 2025 | $544.8M |
| Gross Profit restated | Q3 2025 · Mar 31, 2024 | $216.53M |
| Gross Profit restated | Q3 2025 · Mar 31, 2024 | $635.31M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $68.21M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $205M |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2024 | $70.34M |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2024 | $200.46M |
| Revenue | Q3 2025 · Mar 31, 2025 | $261.38M |
| Revenue | Q3 2025 · Mar 31, 2025 | $749.79M |
| Revenue restated | Q3 2025 · Mar 31, 2024 | $286.87M |
| Revenue restated | Q3 2025 · Mar 31, 2024 | $835.76M |